These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
296 related articles for article (PubMed ID: 2611486)
1. The mechanism of tetrahydroaminoacridine-evoked release of endogenous 5-hydroxytryptamine and dopamine from rat brain tissue prisms. Robinson TN; De Souza RJ; Cross AJ; Green AR Br J Pharmacol; 1989 Dec; 98(4):1127-36. PubMed ID: 2611486 [TBL] [Abstract][Full Text] [Related]
2. Trace amines inhibit the electrically evoked release of [3H]acetylcholine from slices of rat striatum in the presence of pargyline: similarities between beta-phenylethylamine and amphetamine. Baud P; Arbilla S; Cantrill RC; Scatton B; Langer SZ J Pharmacol Exp Ther; 1985 Oct; 235(1):220-9. PubMed ID: 3930699 [TBL] [Abstract][Full Text] [Related]
3. Blockade of nicotinic responses by physostigmine, tacrine and other cholinesterase inhibitors in rat striatum. Clarke PB; Reuben M; el-Bizri H Br J Pharmacol; 1994 Mar; 111(3):695-702. PubMed ID: 8019748 [TBL] [Abstract][Full Text] [Related]
4. Effect of nicotine and tacrine on acetylcholine release from rat cerebral cortical slices. Loiacono RE; Mitchelson FJ Naunyn Schmiedebergs Arch Pharmacol; 1990 Jul; 342(1):31-5. PubMed ID: 2402302 [TBL] [Abstract][Full Text] [Related]
5. Interactions of methylenedioxymethamphetamine with monoamine transmitter release mechanisms in rat brain slices. Fitzgerald JL; Reid JJ Naunyn Schmiedebergs Arch Pharmacol; 1993 Mar; 347(3):313-23. PubMed ID: 8097569 [TBL] [Abstract][Full Text] [Related]
6. Characterisation of dopamine and serotonin uptake inhibitory effects of tetrahydroaminoacridine in rat brain. Jossan SS; Adem A; Winblad B; Oreland L Pharmacol Toxicol; 1992 Sep; 71(3 Pt 1):213-5. PubMed ID: 1438045 [TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of 1,2,3,4-tetrahydro-9-aminoacridine on the depolarization-induced release of GABA from cerebral cortex. de Belleroche J; Gardiner IM Br J Pharmacol; 1988 Aug; 94(4):1017-9. PubMed ID: 3207970 [TBL] [Abstract][Full Text] [Related]
8. Differential effects of d-fenfluramine and p-chloroamphetamine on H75/12-induced depletion of 5-hydroxytryptamine and dopamine in the rat brain. Fattaccini CM; Gozlan H; Hamon M Neuropharmacology; 1991 Jan; 30(1):15-23. PubMed ID: 1710793 [TBL] [Abstract][Full Text] [Related]
9. Measurements of tacrine and monoamines in brain by in vivo microdialysis argue against release of monoamines by tacrine at therapeutic doses. Baldwin HA; De Souza RJ; Sarna GS; Murray TK; Green AR; Cross AJ Br J Pharmacol; 1991 Aug; 103(4):1946-50. PubMed ID: 1912982 [TBL] [Abstract][Full Text] [Related]
10. Carrier-dependent and Ca(2+)-dependent 5-HT and dopamine release induced by (+)-amphetamine, 3,4-methylendioxymethamphetamine, p-chloroamphetamine and (+)-fenfluramine. Crespi D; Mennini T; Gobbi M Br J Pharmacol; 1997 Aug; 121(8):1735-43. PubMed ID: 9283711 [TBL] [Abstract][Full Text] [Related]
11. In vitro studies on the mechanism by which (+)-norfenfluramine induces serotonin and dopamine release from the vesicular storage pool. Gobbi M; Parazzoli A; Mennini T Naunyn Schmiedebergs Arch Pharmacol; 1998 Sep; 358(3):323-7. PubMed ID: 9774219 [TBL] [Abstract][Full Text] [Related]
12. Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. I. Release in the absence of vesicular transmitter stores. Parker EM; Cubeddu LX J Pharmacol Exp Ther; 1986 Apr; 237(1):179-92. PubMed ID: 3007736 [TBL] [Abstract][Full Text] [Related]
13. Attenuation of serotonin-suppressed [3H]acetylcholine release by tetrahydroaminoacridine and dendrotoxin: interaction with minaprine binding site. Muramatsu M; Chaki S; Usuki-ito C; Otomo S Res Commun Chem Pathol Pharmacol; 1990 May; 68(2):131-42. PubMed ID: 2353129 [TBL] [Abstract][Full Text] [Related]
14. Investigation of the presynaptic effects of quinine and quinidine on the release and uptake of monoamines in rat brain tissue. Clement EM; Grahame-Smith DG; Elliott JM Neuropharmacology; 1998 Jul; 37(7):945-51. PubMed ID: 9776390 [TBL] [Abstract][Full Text] [Related]
15. The mechanism by which monoamine oxidase inhibitors give rise to a non-calcium-dependent component in the depolarization-induced release of 5-HT from rat brain synaptosomes. Evans SM; Collard KJ Br J Pharmacol; 1988 Nov; 95(3):950-6. PubMed ID: 3264736 [TBL] [Abstract][Full Text] [Related]
16. 9-Amino-1,2,3,4-tetrahydroacridine (THA), an alleged drug for the treatment of Alzheimer's disease, inhibits acetylcholinesterase activity and slow outward K+ current. Drukarch B; Kits KS; Van der Meer EG; Lodder JC; Stoof JC Eur J Pharmacol; 1987 Sep; 141(1):153-7. PubMed ID: 2444444 [TBL] [Abstract][Full Text] [Related]
17. The cholinergic pharmacology of tetrahydroaminoacridine in vivo and in vitro. Hunter AJ; Murray TK; Jones JA; Cross AJ; Green AR Br J Pharmacol; 1989 Sep; 98(1):79-86. PubMed ID: 2804555 [TBL] [Abstract][Full Text] [Related]
18. 1-(m-chlorophenyl)piperazine (mCPP) dissociates in vivo serotonin release from long-term serotonin depletion in rat brain. Baumann MH; Ayestas MA; Dersch CM; Rothman RB Neuropsychopharmacology; 2001 May; 24(5):492-501. PubMed ID: 11282249 [TBL] [Abstract][Full Text] [Related]
19. Tetrahydroaminoacridine but not 4-aminopyridine inhibits high-affinity choline uptake in striatal and hippocampal synaptosomes. Buyukuysal RL; Wurtman RJ Brain Res; 1989 Mar; 482(2):371-5. PubMed ID: 2539887 [TBL] [Abstract][Full Text] [Related]
20. Evidence of an exocytotic-like release of [3H]5-hydroxytryptamine induced by d-fenfluramine in rat hippocampal synaptosomes. Gobbi M; Frittoli E; Uslenghi A; Mennini T Eur J Pharmacol; 1993 Jul; 238(1):9-17. PubMed ID: 8405087 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]